drug · unknown
RYTELO
updated 6mo agoby $GERN GERON CORP🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 2Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for anemia and 5 investigational indications.
targets
Telomerase reverse transcriptase
all catalysts(0)
nothing on the calendar yet
Trials studying RYTELO
- phase2Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
- phase1A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
- phase3Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
News(1)
- Geron’s Rytelo stumbles in phase 3 as Novartis gears up for post-JAK inhibitor blood cancer bidGeron has discontinued a phase 3 trial of its Rytelo in JAK inhibitor-pretreated myelofibrosis after an independent data monitoring committee ruled that the study was unlikely to succeed, just as N…fiercebiotech · 19d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that